Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

DPYD Antikörper

Der Kaninchen-Polyklonal Anti-DPYD-Antikörper wurde für WB, IHC und ELISA validiert. Er ist geeignet zum Nachweis von DPYD in Proben aus Human. }
Produktnummer ABIN7178655
-15% Promotion 2026
372,13 €
437,80 €
Sparen Sie 65,67 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
100 μL
Lieferung nach: Deutschland
Lieferung in 11 bis 15 Werktagen

Kurzübersicht für DPYD Antikörper (ABIN7178655)

Target

Alle DPYD Antikörper anzeigen
DPYD (Dihydropyrimidine Dehydrogenase (DPYD))

Reaktivität

  • 57
  • 18
  • 15
  • 1
  • 1
  • 1
Human

Wirt

  • 57
  • 3
Kaninchen

Klonalität

  • 46
  • 14
Polyklonal

Konjugat

  • 26
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser DPYD Antikörper ist unkonjugiert

Applikation

  • 47
  • 18
  • 15
  • 14
  • 14
  • 13
  • 13
  • 11
  • 7
  • 5
  • 3
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
  • Verwendungszweck

    DPYD Antibody

    Kreuzreaktivität

    Maus, Ratte

    Aufreinigung

    Affinity purification

    Immunogen

    Recombinant protein of Human DPYD

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    DPYD (Dihydropyrimidine Dehydrogenase (DPYD))

    Andere Bezeichnung

    DPYD

    Hintergrund

    Background: Dihydropyrimidine dehydrogenase (DPD, DPYD) catalyzes the initial and rate-limiting step in uracil and thymidine catabolism as well as catabolism of the chemotherapeutic drug 5-fluorouracil (5-FU) and its derivatives. DPYD deficiency, which results from mutations in the DPYD gene, causes errors in pyrimidine metabolism and potentially life-threatening side effects in cancer patients treated with 5-FU (reviewed in 1). As a result, ongoing work examines whether or how DPYD gene variation and protein expression can be used to predict 5-FU toxicity. Several genes that impart resistance to 5-FU were recently identified in human hepatocellular carcinoma (HCC). AEG-1, which is highly expressed in HCC, increases the expression of DPYD. DPYD is expressed more highly in HCC than in normal liver, and this is thought to be one mechanism of 5-FU resistance.

    Aliases: DHP antibody, DHPDHase antibody, Dihydropyrimidine dehydrogenase [NADP(+)] antibody, Dihydropyrimidine dehydrogenase [NADP+] antibody, Dihydropyrimidine dehydrogenase antibody, Dihydrothymine dehydrogenase antibody, Dihydrouracil dehydrogenase antibody, DPD antibody, DPYD antibody, DPYD_HUMAN antibody, MGC132008 antibody, MGC70799 antibody, OTTHUMP00000058954 antibody

    UniProt

    Q12882

    Pathways

    Ribonucleoside Biosynthetic Process
Sie sind hier:
Chat with us!